These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 4009948)

  • 1. [Clinical experience with BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagata K; Yokoyama M
    Jpn J Antibiot; 1985 Feb; 38(2):263-8. PubMed ID: 4009948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Miyachi Y; Ueda S; Hayakawa F; Nakashima T; Hakamada S; Kuno K
    Jpn J Antibiot; 1985 Feb; 38(2):423-30. PubMed ID: 4009951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental and clinical evaluation of the BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Shinozaki T; Meguro H; Fujii R; Mashiko Z; Okamoto Y; Arimasu O
    Jpn J Antibiot; 1985 Feb; 38(2):269-86. PubMed ID: 4009949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sunakawa K; Ishizuka Y
    Jpn J Antibiot; 1985 Feb; 38(2):319-26. PubMed ID: 3892075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laboratory and clinical studies on BRL 25000 (clavulanic acid -amoxicillin) granules in the pediatric field].
    Cho K; Sakata H; Fujita K; Yoshioka H; Mukai N
    Jpn J Antibiot; 1985 Feb; 38(2):253-62. PubMed ID: 4009947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1985 Feb; 38(2):309-18. PubMed ID: 3847520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Haruta T; Kuroki S; Okura K; Kobayashi Y
    Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
    Minamitani M; Hachimori K; Kaneda K
    Jpn J Antibiot; 1985 Feb; 38(2):415-22. PubMed ID: 4009950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagamatsu I; Horiguchi S; Hatae T
    Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
    Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K; Nakada Y; Niino K
    Jpn J Antibiot; 1985 Feb; 38(2):296-308. PubMed ID: 3847519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
    Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules on skin and soft tissue infections in the field of pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
    Jpn J Antibiot; 1985 Feb; 38(2):507-37. PubMed ID: 3892077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amoxicillin-clavulanic acid (Augmentin).
    Med Lett Drugs Ther; 1984 Nov; 26(674):99-100. PubMed ID: 6387417
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) in the fields of obstetrics and gynecology].
    Kishida H; Kisaka Y; Matsubayashi S; Hiraoka H; Naitoh H; Tanaka S; Urabe T; Fujiwara A
    Jpn J Antibiot; 1983 Mar; 36(3):487-99. PubMed ID: 6553605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
    Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
    Tan TH; Tay L; Yeo M; Feng PH
    Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequential intravenous-oral amoxycillin/clavulanate (Augmentin) therapy in paediatric hospital practice.
    Schaad UB; Pfenninger J; Wedgewood-Krucko J
    J Antimicrob Chemother; 1987 Mar; 19(3):385-91. PubMed ID: 3571053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.